oscaraft Saturday, 01/17/15 12:41:16 PM Re: None Post # of 137 GSK to skyrocket to $100+ with Ebola Vaccine - There is very little doubt that GSK will skyrocket to $100 + once the Ebola vaccine comes out at the end of this month. This is an incredible opportunity! $100 - $125 would not be unreasonable in the short term. GSK is definitely a strong buy at the moment and possibly the chance of a lifetime. Fasten your seat belts folks! A huge run is coming with GSK!